Selma, M. V. Et Al. 2018. The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome. CLINICAL NUTRITION , vol.37, no.3 , 897-905.

Selma, M. V., Gonzalez-Sarrias, A., Salas-Salvado, J., Andres-Lacueva, C., Alasalvar, C., ÖREM, A., ... Tomas-Barberan, F. A.(2018). The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome. CLINICAL NUTRITION , vol.37, no.3, 897-905.

Selma, Maria Et Al. "The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome," CLINICAL NUTRITION , vol.37, no.3, 897-905, 2018

Selma, Maria V. Et Al. "The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome." CLINICAL NUTRITION , vol.37, no.3, pp.897-905, 2018

Selma, M. V. Et Al. (2018) . "The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome." CLINICAL NUTRITION , vol.37, no.3, pp.897-905.

@article{article, author={Maria V. Selma Et Al. }, title={The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome}, journal={CLINICAL NUTRITION}, year=2018, pages={897-905} }